TCRT Stock Analysis: Buy, Sell, or Hold?
TCRT - Alaunos Therapeutics, Inc. Common Stock
$1.67
0.01 (0.60%)
▲
5d:
-5.97%
30d:
-12.11%
90d:
-36.26%
WAIT
LOW Confidence
Analysis Updated: Sep 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When TCRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TCRT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TCRT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: TCRT is currently trading at $1.67, which is considered oversold relative to its 30-day fair value range of $1.74 to $1.98.
Technical Outlook: Technically, TCRT is in a strong downtrend. Immediate support is located at $1.55, while resistance sits at $1.97.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TCRT is in a strong downtrend. Immediate support is located at $1.55, while resistance sits at $1.97.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.74 -
$1.98
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($1.75)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.74 -
$1.98
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.55
Resistance Level
$1.97
Current Trend
Strong Downtrend
Technical data as of
Sep 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.48
Wall Street Target
$1.75
(+5.4%)
Revenue Growth (YoY)
-25.0%
Share & Embed Analysis
Last updated: September 02, 2026 6:53 PM ET
Data refreshes hourly during market hours. Next update: 7:53 PM
Data refreshes hourly during market hours. Next update: 7:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 38 SELL |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$563 | 40 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
